rs3744328

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000465567.1(TTC19):​n.1583T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0392 in 1,602,908 control chromosomes in the GnomAD database, including 2,377 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 845 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1532 hom. )

Consequence

TTC19
ENST00000465567.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0240

Publications

11 publications found
Variant links:
Genes affected
TTC19 (HGNC:26006): (tetratricopeptide repeat domain 19) This gene encodes a protein with a tetratricopeptide repeat (TPR) domain containing several TPRs of about 34 aa each. These repeats are found in a variety of organisms including bacteria, fungi and plants, and are involved in a variety of functions including protein-protein interactions. This protein is embedded in the inner mitochondrial membrane and is involved in the formation of the mitochondrial respiratory chain III. It has also been suggested that this protein plays a role in cytokinesis. Mutations in this gene cause mitochondrial complex III deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2012]
TTC19 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial complex III deficiency nuclear type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • mitochondrial complex III deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 17-16027568-T-C is Benign according to our data. Variant chr17-16027568-T-C is described in ClinVar as Benign. ClinVar VariationId is 321952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC19NM_017775.4 linkc.*46T>C 3_prime_UTR_variant Exon 10 of 10 ENST00000261647.10 NP_060245.3 Q6DKK2A0A024RD83
TTC19NM_001271420.2 linkc.*46T>C 3_prime_UTR_variant Exon 10 of 10 NP_001258349.1 Q6DKK2
TTC19XM_017024801.3 linkc.994+866T>C intron_variant Intron 9 of 9 XP_016880290.2
TTC19XM_017024802.3 linkc.994+866T>C intron_variant Intron 9 of 9 XP_016880291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC19ENST00000261647.10 linkc.*46T>C 3_prime_UTR_variant Exon 10 of 10 1 NM_017775.4 ENSP00000261647.5 Q6DKK2

Frequencies

GnomAD3 genomes
AF:
0.0782
AC:
11895
AN:
152046
Hom.:
836
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0584
Gnomad ASJ
AF:
0.0268
Gnomad EAS
AF:
0.0740
Gnomad SAS
AF:
0.0538
Gnomad FIN
AF:
0.0412
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0266
Gnomad OTH
AF:
0.0729
GnomAD2 exomes
AF:
0.0507
AC:
12647
AN:
249310
AF XY:
0.0468
show subpopulations
Gnomad AFR exome
AF:
0.200
Gnomad AMR exome
AF:
0.0555
Gnomad ASJ exome
AF:
0.0273
Gnomad EAS exome
AF:
0.0759
Gnomad FIN exome
AF:
0.0411
Gnomad NFE exome
AF:
0.0278
Gnomad OTH exome
AF:
0.0452
GnomAD4 exome
AF:
0.0351
AC:
50960
AN:
1450744
Hom.:
1532
Cov.:
26
AF XY:
0.0349
AC XY:
25231
AN XY:
722360
show subpopulations
African (AFR)
AF:
0.201
AC:
6684
AN:
33234
American (AMR)
AF:
0.0567
AC:
2533
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0286
AC:
744
AN:
26044
East Asian (EAS)
AF:
0.0541
AC:
2143
AN:
39626
South Asian (SAS)
AF:
0.0500
AC:
4290
AN:
85848
European-Finnish (FIN)
AF:
0.0405
AC:
2127
AN:
52566
Middle Eastern (MID)
AF:
0.0503
AC:
289
AN:
5742
European-Non Finnish (NFE)
AF:
0.0266
AC:
29380
AN:
1102962
Other (OTH)
AF:
0.0461
AC:
2770
AN:
60032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
2650
5300
7951
10601
13251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1294
2588
3882
5176
6470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0784
AC:
11924
AN:
152164
Hom.:
845
Cov.:
32
AF XY:
0.0785
AC XY:
5843
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.190
AC:
7882
AN:
41514
American (AMR)
AF:
0.0584
AC:
892
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0268
AC:
93
AN:
3466
East Asian (EAS)
AF:
0.0742
AC:
384
AN:
5176
South Asian (SAS)
AF:
0.0541
AC:
260
AN:
4806
European-Finnish (FIN)
AF:
0.0412
AC:
437
AN:
10600
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0266
AC:
1811
AN:
68010
Other (OTH)
AF:
0.0716
AC:
151
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
519
1037
1556
2074
2593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0410
Hom.:
448
Bravo
AF:
0.0848
Asia WGS
AF:
0.0580
AC:
204
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mitochondrial complex III deficiency nuclear type 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
3.2
DANN
Benign
0.65
PhyloP100
-0.024
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744328; hg19: chr17-15930882; COSMIC: COSV51966311; COSMIC: COSV51966311; API